Skip to main content
OpenTrials

Clinical trial condition

Acute Lymphoblastic Leukemia (ALL)

Explore clinical trials studying Acute Lymphoblastic Leukemia (ALL). Study availability and eligibility vary by location and protocol.

41 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia (ALL) trial results

Completed

Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia

NCT00495079

Conditions
Acute Lymphoblastic Leukemia (ALL), Disease Attributes, Hematologic Diseases, +13 more
Locations
  • USC - Norris Cancer Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California Medical Center San Francisco, California, United States
  • Stanford Hospitals and Clinics Stanford, California, United States
View all 33 locations
View Trial Details
Completed

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

NCT01816230

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Steven and Alexandra Cohen Children's Medical Center New York, United States
View all 15 locations
View Trial Details
Completed

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NCT02212561

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL

NCT01305655

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Department of Pediatrics, Rigshospitalet Copenhagen, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • University of Reykjavik Reykjavik, Iceland
  • University Hospital of Trondheim Trondheim, Norway
View Trial Details
Completed

An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients

NCT02238925

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +19 more
Locations
  • Franciscan Saint Francis Health Indianapolis, Indiana, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Completed

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

NCT01527838

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
  • Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions